| Erlotinib in previously treated non–small-cell lung cancer FA Shepherd, J Rodrigues Pereira, T Ciuleanu, EH Tan, V Hirsh, ... New England journal of medicine 353 (2), 123-132, 2005 | 7006 | 2005 |
| K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer CS Karapetis, S Khambata-Ford, DJ Jonker, CJ O'Callaghan, D Tu, ... New England Journal of Medicine 359 (17), 1757-1765, 2008 | 4464 | 2008 |
| The jackknife and bootstrap J Shao, D Tu Springer Science & Business Media, 2012 | 3367 | 2012 |
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ... New England Journal of Medicine 349 (3), 247-257, 2003 | 2684 | 2003 |
| Cetuximab for the treatment of colorectal cancer DJ Jonker, CJ O'Callaghan, CS Karapetis, JR Zalcberg, D Tu, HJ Au, ... New England Journal of Medicine 357 (20), 2040-2048, 2007 | 2423 | 2007 |
| A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... New England Journal of Medicine 349 (19), 1793-1802, 2003 | 2421 | 2003 |
| Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17 PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... Journal of the National Cancer Institute 97 (17), 1262-1271, 2005 | 1464 | 2005 |
| Morphine, gabapentin, or their combination for neuropathic pain I Gilron, JM Bailey, D Tu, RR Holden, DF Weaver, RL Houlden New England Journal of Medicine 352 (13), 1324-1334, 2005 | 1450 | 2005 |
| Exemestane for breast-cancer prevention in postmenopausal women PE Goss, JN Ingle, JE Alés-Martínez, AM Cheung, RT Chlebowski, ... New England Journal of Medicine 364 (25), 2381-2391, 2011 | 1143 | 2011 |
| Association of KRAS p. G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab W De Roock, DJ Jonker, F Di Nicolantonio, A Sartore-Bianchi, D Tu, ... Jama 304 (16), 1812-1820, 2010 | 877 | 2010 |
| Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women … MN Levine, VH Bramwell, KI Pritchard, BD Norris, LE Shepherd, ... Journal of Clinical oncology 16 (8), 2651-2658, 1998 | 755 | 1998 |
| HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy KI Pritchard, LE Shepherd, FP O'Malley, IL Andrulis, D Tu, VH Bramwell, ... New England Journal of Medicine 354 (20), 2103-2111, 2006 | 729 | 2006 |
| Extending aromatase-inhibitor adjuvant therapy to 10 years PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, ... New England Journal of Medicine 375 (3), 209-219, 2016 | 698 | 2016 |
| Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma AM Davis, B O'Sullivan, R Turcotte, R Bell, C Catton, P Chabot, J Wunder, ... Radiotherapy and oncology 75 (1), 48-53, 2005 | 689 | 2005 |
| Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. E Mitry, AL Fields, H Bleiberg, R Labianca, G Portier, D Tu, D Nitti, V Torri, ... | 659 | 2008 |
| Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix R Pearcey, M Brundage, P Drouin, J Jeffrey, D Johnston, H Lukka, ... Journal of Clinical Oncology 20 (4), 966-972, 2002 | 644 | 2002 |
| Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial I Gilron, JM Bailey, D Tu, RR Holden, AC Jackson, RL Houlden The Lancet 374 (9697), 1252-1261, 2009 | 612 | 2009 |
| Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN. 5 randomised trials): pooled trial results, systematic review, and meta … T ASTEC The Lancet 373 (9658), 137-146, 2009 | 550 | 2009 |
| Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of … MJ Moore, J Hamm, J Dancey, PD Eisenberg, M Dagenais, A Fields, ... Journal of clinical oncology 21 (17), 3296-3302, 2003 | 469 | 2003 |
| Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21 A Bezjak, D Tu, L Seymour, G Clark, A Trajkovic, M Zukin, J Ayoub, ... J Clin Oncol 24 (24), 3831-3837, 2006 | 464 | 2006 |
Lois ShepherdProfessorVerified email at ctg.queensu.ca
